Drug Puts A $750,000 ‘Price Tag On Life’

05:00 EDT 2 Aug 2017 | Kaiser Health News

The high cost of Spinraza, a new and promising treatment for spinal muscular atrophy, highlights how the cost-benefit analysis insurers use to make drug coverage decisions plays out in human terms.

Original Article: Drug Puts A $750,000 ‘Price Tag On Life’


More From BioPortfolio on "Drug Puts A $750,000 ‘Price Tag On Life’"

Quick Search

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...